Paloma Partners Management CO Novo Cure LTD Transaction History

Paloma Partners Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $126,276 - $211,475	-1,087 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $67,416 - $116,624	-517 Reduced 32.23%	1,087 $241,000
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $199,072 - $305,032	1,604 New	1,604 $212,000
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $5.98 Million - $11.5 Million	-103,037 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $5.89 Million - $7.67 Million	103,037 New	103,037 $6.11 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $892,262 - $1.5 Million	-15,640 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $2.35 Million - $3.23 Million	-34,462 Reduced 68.78%	15,640 $1.32 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $3.1 Million - $4.9 Million	50,102 New	50,102 $3.75 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.